Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/11569
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | The interference of pharmaceuticals with endogenous and xenobiotic metabolizing enzymes in carp liver: an in-vitro study |
Autor: | Thibaut, Rémi CSIC; Schnell, Sabine CSIC; Porte Visa, Cinta CSIC ORCID | Palabras clave: | Xenobiotic In vitro Liver Enzyme Drug Interference |
Fecha de publicación: | 7-jul-2006 | Editor: | American Chemical Society | Citación: | Environmental Science & Technology 40(16): 5154-5160 (2006) | Resumen: | The interactions of fibrate (clofibrate, fenofibrate, bezafibrate, gemfibrozil), antiinflammatory (ibuprofen, diclofenac, naproxen, ketoprofen), and anti-depressive (fluoxetine, fluvoxamine, paroxetine) drugs with CYP catalyzed pathways (CYP1A, CYP3A-, CYP2K-, and CYP2M-like) and Phase II activities (UDP-glucuronosyltransferases and sulfotransferases), involved in both xenobiotic and endogenous metabolism in fish, were investigated in-vitro by incubating carp liver subcellular fractions in the presence of the substrate and the selected drug. Antidepressive drugs were strong inhibitors of CYP1A (92-94% inhibition), CYP3A-like (69-80% inhibition), and CYP2Klike (36-69% inhibition) catalyzed activities, while antiinflammatory drugs were potent CYP2M-like inhibitors (32-74% inhibition). Among the lipid regulators, gemfibrozil strongly inhibited CYP2M-catalyzed activity (91% inhibition) and other CYP isoforms (CYP1A and CYP3A-like). Additionally, glucuronidation of naphthol and testosterone were targeted by antiinflammatory drugs, and to a lesser extent, by fibrate drugs (48-78% inhibition). No significant alteration on sulfotransferase activities was observed, apart from a minor inhibitory effect of clofibrate, gemfibrozil, and fluoxetine on the sulfation of estradiol. Overall, gemfibrozil, diclofenac, and the three anti-depressive drugs appear to be the pharmaceuticals with the highest potential to interfere with fish metabolic systems. | Descripción: | 7 pages, 2 figures.-- PMID: 16955921 [PubMed].-- Printed version published Aug 15, 2006. | Versión del editor: | http://dx.doi.org/10.1021/es0607483 | URI: | http://hdl.handle.net/10261/11569 | DOI: | 10.1021/es0607483 | ISSN: | 0013-936x | E-ISSN: | 1520-5851 |
Aparece en las colecciones: | (IDAEA) Artículos |
Mostrar el registro completo
CORE Recommender
SCOPUSTM
Citations
77
checked on 09-abr-2024
WEB OF SCIENCETM
Citations
74
checked on 28-feb-2024
Page view(s)
360
checked on 18-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.